Infrainguinal arterial bypass with autologous vein has proven effective and durable over nearly 60 years. Less invasive endovascular treatment has emerged as a formidable competitor to the vein bypass. In many, if not most cases, the choice of one modality over the other is clear. However, there are situations where the decision is not so obvious. It is in such cases that the careful consideration of all patient and anatomic factors by the experienced vascular specialist who can offer both open surgical bypass and endovascular treatment is likely to lead to better outcomes. This article and presentation will attempt to provide some guidelines that the reader may consider when making such choices.
Norgren L., Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; TASC II Working Group.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl):S5-67.
3.
Walsh N.Experts disagree on open vs. endo for limb ischemia. Long-term BASIL results favor open. Vasc Specialist. 2009;5:1, 6.
4.
Kunlin J.Long vein transplantation in treatment of ischemia caused by arteritis [in French]. Rev Chir. 1951;70:206-235.
5.
Leather RP, Powers SR, Karmody AMA reappraisal of the in situ saphenous vein arterial bypass: its use in limb salvage. Surgery. 1979;86:453-461.
6.
Dotter CT, Judkins MPTransluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation . 1964;30: 654-670.
7.
Grüntzig A., Hopff H.Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) [in German]. Dtsch Med Wochenschr. 1974;99:2502-2510.
8.
Bolia A., Miles KA, Brennan J., Bell PRPercutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol . 1990;13:357-363.
9.
Lipsitz EC, Veith FJ, Ohki T.Subintimal angioplasty in the management of critical lower-extremity ischemia: value in limb salvage. Perspect Vasc Surg Endovasc Ther. 2005;17: 11-20.
10.
Treiman GS, Treiman R., Whiting J.Results of percutaneous subintimal angioplasty using routine stenting. J Vasc Surg. 2006;43:513-519.
11.
Muradin GS, Bosch JL, Stijnen T., Hunink MGBalloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology. 2001;221: 137-145.
12.
Mewissen MWSelf-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasc Interv Radiol. 2004;7:2-5.
13.
Adam DJ, Beard JD, Cleveland T., et al.; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.
14.
Mayer PTLeaders in Vascular and Endovascular Community Debate Bypass Versus Infrapopliteal Balloon Angioplasty. http://www.medicalnewstoday.com/articles/130500.php. Accessed August 2, 2009.
15.
Illig KA, Zhang R., Tanski W., Benesch C., Sternbach Y., Green RMIs the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified? J Vasc Surg. 2003;37:575-581.
16.
Hynes N., Akhtar Y., Manning B., et al. Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Endovasc Ther. 2004;11:460-471.
17.
Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., Gable D.Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease . J Vasc Surg. 2007;45:10-16.
18.
Muradin GS, Myriam Hunink MGCost and patency rate targets for the development of endovascular devices to treat femoropopliteal arterial disease. Radiology. 2001;218:464-469.
19.
Duda SH, Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
